535 related articles for article (PubMed ID: 30925076)
1. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
2. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
[TBL] [Abstract][Full Text] [Related]
3. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
4. Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma.
Zhao L; Yang J; Wang HP; Liu RY
Med Oncol; 2013 Mar; 30(1):461. PubMed ID: 23335103
[TBL] [Abstract][Full Text] [Related]
5. Expression of Th17 and CD4
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
[TBL] [Abstract][Full Text] [Related]
6. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
[TBL] [Abstract][Full Text] [Related]
7. Aberrant peripheral blood CD4
Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N
Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519
[TBL] [Abstract][Full Text] [Related]
8. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.
Hou PF; Zhu LJ; Chen XY; Qiu ZQ
PLoS One; 2017; 12(3):e0173048. PubMed ID: 28253320
[TBL] [Abstract][Full Text] [Related]
10. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
11. Increased IL-10+CD206+CD14+M2-like macrophages in alveolar lavage fluid of patients with small cell lung cancer.
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Immunol Immunother; 2020 Dec; 69(12):2547-2560. PubMed ID: 32583155
[TBL] [Abstract][Full Text] [Related]
12. The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN.
Wang YY; He XY; Cai YY; Wang ZJ; Lu SH
Target Oncol; 2011 Sep; 6(3):147-54. PubMed ID: 21611754
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.
Xu F; Yu S; Qin M; Mao Y; Jin L; Che N; Liu S; Ge R
Inflammation; 2018 Feb; 41(1):81-92. PubMed ID: 28894978
[TBL] [Abstract][Full Text] [Related]
14. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
15. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
[TBL] [Abstract][Full Text] [Related]
16. T Helper Cells Profile and CD4+CD25+Foxp3+Regulatory T Cells in Polycystic Ovary Syndrome.
Nasri F; Doroudchi M; Namavar Jahromi B; Gharesi-Fard B
Iran J Immunol; 2018 Sep; 15(3):175-185. PubMed ID: 30246693
[TBL] [Abstract][Full Text] [Related]
17. CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.
Ju S; Qiu H; Zhou X; Zhu B; Lv X; Huang X; Li J; Zhang Y; Liu L; Ge Y; Johnson DE; Ju S; Shu Y
Cell Cycle; 2009 Aug; 8(16):2578-85. PubMed ID: 19597336
[TBL] [Abstract][Full Text] [Related]
18. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.
Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J
APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667
[TBL] [Abstract][Full Text] [Related]
19. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
[TBL] [Abstract][Full Text] [Related]
20. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
Deng M; Li MH; Liu SA; Liu F; Sang Y; Song SJ; Zang SF; Guan XP; Yao X; Wu XP; Cheng J; Xu DZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):21-3. PubMed ID: 20848841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
